Volgen
Erik van Werkhoven
Erik van Werkhoven
Johns Hopkins Bloomberg School of Public Health
Geverifieerd e-mailadres voor jhu.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...
The lancet oncology 16 (6), 630-637, 2015
16732015
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
8192019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
SN Ooft, F Weeber, KK Dijkstra, CM McLean, S Kaing, E van Werkhoven, ...
Science translational medicine 11 (513), eaay2574, 2019
6262019
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
S Leijen, SA Burgers, P Baas, D Pluim, M Tibben, E van Werkhoven, ...
Investigational new drugs 33, 201-214, 2015
4872015
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
LM Henricks, CATC Lunenburg, FM de Man, D Meulendijks, ...
The Lancet Oncology 19 (11), 1459-1467, 2018
4212018
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised …
MS van Ramshorst, A van der Voort, ED van Werkhoven, IA Mandjes, ...
The Lancet Oncology 19 (12), 1630-1640, 2018
3612018
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 …
S Leijen, RMJM van Geel, GS Sonke, D de Jong, EH Rosenberg, ...
Journal of Clinical Oncology 34 (36), 4354-4361, 2016
3022016
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
DL van der Velden, LR Hoes, H Van Der Wijngaart, ...
Nature 574 (7776), 127-131, 2019
2402019
Angiotensin II–receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: a randomized clinical trial
AH Boekhout, JA Gietema, BM Kerklaan, ED van Werkhoven, R Altena, ...
JAMA oncology 2 (8), 1030-1037, 2016
2262016
Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival
MC Van Harten, FJP Hoebers, KW Kross, ED Van Werkhoven, ...
Oral oncology 51 (3), 272-278, 2015
2152015
Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial
C Vrieling, E van Werkhoven, P Maingon, P Poortmans, C Weltens, ...
JAMA oncology 3 (1), 42-48, 2017
1662017
Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically …
NM Graafland, W Lam, JAP Leijte, T Yap, MPW Gallee, C Corbishley, ...
European urology 58 (5), 742-747, 2010
1612010
Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study
AR Ribe, TM Laursen, M Charles, W Katon, M Fenger-Grøn, D Davydow, ...
JAMA psychiatry 72 (11), 1095-1101, 2015
1582015
The best of both worlds: a hybrid approach for optimal pre-and intraoperative identification of sentinel lymph nodes
GH KleinJan, E Van Werkhoven, NS van Den Berg, MB Karakullukcu, ...
European journal of nuclear medicine and molecular imaging 45, 1915-1925, 2018
1572018
Comparison of the value of nursing work environments in hospitals across different levels of patient risk
JH Silber, PR Rosenbaum, MD McHugh, JM Ludwig, HL Smith, ...
JAMA surgery 151 (6), 527-536, 2016
1562016
Comparison of the value of nursing work environments in hospitals across different levels of patient risk
JH Silber, PR Rosenbaum, MD McHugh, JM Ludwig, HL Smith, ...
JAMA surgery 151 (6), 527-536, 2016
1562016
Penile sparing surgery for penile cancer—does it affect survival?
RS Djajadiningrat, E van Werkhoven, W Meinhardt, BWG van Rhijn, ...
The Journal of urology 192 (1), 120-126, 2014
1522014
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity
D Meulendijks, LM Henricks, BAW Jacobs, A Aliev, MJ Deenen, ...
British journal of cancer 116 (11), 1415-1424, 2017
1382017
Contemporary management of regional nodes in penile cancer—improvement of survival?
RS Djajadiningrat, NM Graafland, E van Werkhoven, W Meinhardt, A Bex, ...
The Journal of urology 191 (1), 68-73, 2014
1382014
Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome
RS Djajadiningrat, ES Jordanova, BK Kroon, E van Werkhoven, J de Jong, ...
The Journal of urology 193 (2), 526-531, 2015
1342015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20